Logo image of AKAST.OL

AKASTOR ASA (AKAST.OL) Stock Fundamental Analysis

OSL:AKAST - Euronext Oslo - NO0010215684 - Common Stock - Currency: NOK

12.12  -0.04 (-0.33%)

Fundamental Rating

5

Taking everything into account, AKAST scores 5 out of 10 in our fundamental rating. AKAST was compared to 35 industry peers in the Energy Equipment & Services industry. While AKAST has a great health rating, its profitability is only average at the moment. AKAST has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AKAST had positive earnings in the past year.
AKAST had a positive operating cash flow in the past year.
In multiple years AKAST reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: AKAST reported negative operating cash flow in multiple years.
AKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFAKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of 24.64%, AKAST belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
AKAST has a Return On Equity of 28.20%. This is amongst the best in the industry. AKAST outperforms 88.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.44%, AKAST is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
ROA 24.64%
ROE 28.2%
ROIC 7.44%
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
AKAST.OL Yearly ROA, ROE, ROICAKAST.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

AKAST's Profit Margin of 179.18% is amongst the best of the industry. AKAST outperforms 100.00% of its industry peers.
AKAST's Profit Margin has improved in the last couple of years.
AKAST has a Operating Margin of 67.35%. This is amongst the best in the industry. AKAST outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of AKAST has grown nicely.
Industry RankSector Rank
OM 67.35%
PM (TTM) 179.18%
GM N/A
OM growth 3YN/A
OM growth 5Y73.59%
PM growth 3Y21.22%
PM growth 5Y149.19%
GM growth 3YN/A
GM growth 5YN/A
AKAST.OL Yearly Profit, Operating, Gross MarginsAKAST.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKAST is destroying value.
Compared to 1 year ago, AKAST has about the same amount of shares outstanding.
AKAST has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AKAST has been reduced compared to a year ago.
AKAST.OL Yearly Shares OutstandingAKAST.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AKAST.OL Yearly Total Debt VS Total AssetsAKAST.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

AKAST has a debt to FCF ratio of 0.23. This is a very positive value and a sign of high solvency as it would only need 0.23 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.23, AKAST belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that AKAST is not too dependend on debt financing.
The Debt to Equity ratio of AKAST (0.05) is better than 88.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.23
Altman-Z N/A
ROIC/WACC0.99
WACC7.54%
AKAST.OL Yearly LT Debt VS Equity VS FCFAKAST.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

AKAST has a Current Ratio of 3.01. This indicates that AKAST is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.01, AKAST belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
AKAST has a Quick Ratio of 3.01. This indicates that AKAST is financially healthy and has no problem in meeting its short term obligations.
AKAST has a better Quick ratio (3.01) than 88.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.01
Quick Ratio 3.01
AKAST.OL Yearly Current Assets VS Current LiabilitesAKAST.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

AKAST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 737.21%, which is quite impressive.
The Earnings Per Share has been growing by 75.95% on average over the past years. This is a very strong growth
The Revenue has grown by 226.95% in the past year. This is a very strong growth!
Measured over the past years, AKAST shows a very negative growth in Revenue. The Revenue has been decreasing by -29.67% on average per year.
EPS 1Y (TTM)737.21%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%203.77%
Revenue 1Y (TTM)226.95%
Revenue growth 3Y0.33%
Revenue growth 5Y-29.67%
Sales Q2Q%2.27%

3.2 Future

Based on estimates for the next years, AKAST will show a very negative growth in Earnings Per Share. The EPS will decrease by -51.20% on average per year.
Based on estimates for the next years, AKAST will show a very negative growth in Revenue. The Revenue will decrease by -32.24% on average per year.
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AKAST.OL Yearly Revenue VS EstimatesAKAST.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B 15B 20B
AKAST.OL Yearly EPS VS EstimatesAKAST.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.00 indicates a rather cheap valuation of AKAST.
AKAST's Price/Earnings ratio is rather cheap when compared to the industry. AKAST is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. AKAST is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 58.83, which means the current valuation is very expensive for AKAST.
AKAST's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AKAST is more expensive than 74.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AKAST to the average of the S&P500 Index (22.10), we can say AKAST is valued expensively.
Industry RankSector Rank
PE 2
Fwd PE 58.83
AKAST.OL Price Earnings VS Forward Price EarningsAKAST.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKAST indicates a somewhat cheap valuation: AKAST is cheaper than 77.14% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKAST indicates a rather cheap valuation: AKAST is cheaper than 94.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.04
EV/EBITDA 4.5
AKAST.OL Per share dataAKAST.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

AKAST has a very decent profitability rating, which may justify a higher PE ratio.
AKAST's earnings are expected to decrease with -51.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2Y-51.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AKAST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKASTOR ASA

OSL:AKAST (3/10/2025, 11:25:52 AM)

12.12

-0.04 (-0.33%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-30 2025-04-30
Inst Owners17.35%
Inst Owner ChangeN/A
Ins Owners1.64%
Ins Owner ChangeN/A
Market Cap3.32B
Analysts86
Price Target21.93 (80.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.46%
Min Revenue beat(2)0.44%
Max Revenue beat(2)10.48%
Revenue beat(4)3
Avg Revenue beat(4)-2.52%
Min Revenue beat(4)-32.12%
Max Revenue beat(4)11.13%
Revenue beat(8)4
Avg Revenue beat(8)-11.81%
Revenue beat(12)7
Avg Revenue beat(12)-11.68%
Revenue beat(16)9
Avg Revenue beat(16)-16.3%
PT rev (1m)6.61%
PT rev (3m)6.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-56.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.29%
Valuation
Industry RankSector Rank
PE 2
Fwd PE 58.83
P/S 3.6
P/FCF 2.04
P/OCF 1.87
P/B 0.57
P/tB 0.57
EV/EBITDA 4.5
EPS(TTM)6.05
EY49.92%
EPS(NY)0.21
Fwd EY1.7%
FCF(TTM)5.95
FCFY49.08%
OCF(TTM)6.49
OCFY53.57%
SpS3.36
BVpS21.38
TBVpS21.38
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 24.64%
ROE 28.2%
ROCE 9.66%
ROIC 7.44%
ROICexc 7.96%
ROICexgc 7.96%
OM 67.35%
PM (TTM) 179.18%
GM N/A
FCFM 176.79%
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y18.2%
ROICexc growth 3YN/A
ROICexc growth 5Y24.79%
OM growth 3YN/A
OM growth 5Y73.59%
PM growth 3Y21.22%
PM growth 5Y149.19%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.23
Debt/EBITDA 0.46
Cap/Depr 551.85%
Cap/Sales 16.16%
Interest Coverage 250
Cash Conversion 274.54%
Profit Quality 98.67%
Current Ratio 3.01
Quick Ratio 3.01
Altman-Z N/A
F-Score7
WACC7.54%
ROIC/WACC0.99
Cap/Depr(3y)202.64%
Cap/Depr(5y)136.86%
Cap/Sales(3y)8.38%
Cap/Sales(5y)9.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)737.21%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%203.77%
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)226.95%
Revenue growth 3Y0.33%
Revenue growth 5Y-29.67%
Sales Q2Q%2.27%
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2103.23%
EBIT growth 3YN/A
EBIT growth 5Y22.08%
EBIT Next Year-89.58%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y627.51%
FCF growth 3YN/A
FCF growth 5Y42.34%
OCF growth 1Y701.01%
OCF growth 3YN/A
OCF growth 5Y34.38%